GlassScriptPhysician profile
Olga Iris Colon
NPI 1881650158
$1,408.65
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $415 · 2022: $527 · 2023: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $252.13 | 2021-2023 | |
| Pfizer INC. | $167.76 | 2021-2023 | |
| Abbott Laboratories | $159.28 | 2022-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $151.49 | 2021-2023 | Mounjaro |
| Novo Nordisk INC | $123.38 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.75 | 2022-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.15 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $82.59 | 2022-2023 | Ztlido |
| Lifescan, INC. | $43.42 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.61 | 2023 | |
| Glaxosmithkline, LLC. | $34.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $30.28 | 2021-2022 | |
| Exact Sciences Corporation | $25.02 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $24.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.57 | 2023 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.67 | 2023 | Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $17.33 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.